Leaflet: Infographic on Article 58 procedure

15 février 2019

BlueRegWatch

Article 58 of Regulation (EC) No 726/2004 establishes a mechanism whereby the European Medicines Agency (EMA) may give a scientific opinion, in the context of cooperation with the World Health Organisation (WHO), for the evaluation of certain medicinal products for human use intended exclusively for markets outside the European Union (…)

BlueRegWatch

Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :

Découvrez notre dernier livre blanc

En savoir plus